Legal & General Group’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.3K | Buy |
+5,833
| New | +$23.3K | ﹤0.01% | 2946 |
|
|
2019
Q3 | – | Sell |
-2,059
| Closed | -$7K | – | 3367 |
|
|
2019
Q2 | $7K | Hold |
2,059
| – | – | ﹤0.01% | 3414 |
|
|
2019
Q1 | $8K | Hold |
2,059
| – | – | ﹤0.01% | 3273 |
|
|
2018
Q4 | $8K | Hold |
2,059
| – | – | ﹤0.01% | 3285 |
|
|
2018
Q3 | $18K | Hold |
2,059
| – | – | ﹤0.01% | 3233 |
|
|
2018
Q2 | $23K | Buy |
2,059
+864
| +72% | +$9.65K | ﹤0.01% | 3126 |
|
|
2018
Q1 | $14K | Hold |
1,195
| – | – | ﹤0.01% | 3170 |
|
|
2017
Q4 | $12K | Sell |
1,195
-851
| -42% | -$8.55K | ﹤0.01% | 3217 |
|
|
2017
Q3 | $33K | Buy |
2,046
+1,292
| +171% | +$20.8K | ﹤0.01% | 3037 |
|
|
2017
Q2 | $9K | Hold |
754
| – | – | ﹤0.01% | 3325 |
|
|
2017
Q1 | $16K | Hold |
754
| – | – | ﹤0.01% | 3125 |
|
|
2016
Q4 | $11K | Buy |
+754
| New | +$11K | ﹤0.01% | 3203 |
|